Orange Health Labs hits ₹180 cr ARR betting diagnostics is the next quick-commerce category
The Accel- and General Catalyst-backed startup is running a Zepto-style playbook for blood tests — 60-minute home collection, 6-hour reports — across Bengaluru, Delhi, Hyderabad and Mumbai. Bengaluru alone clocks 300,000 samples a month at 20% Ebitda margins, putting it on a collision course with Dr Lal, Metropolis and Tata 1mg.
What happened
Orange Health Labs is scaling a quick-commerce-style diagnostics model with 60-minute home sample collection and 6-hour reports, hitting ₹180 crore ARR across
Key facts
- ARR ₹180 crore
- 300,000 samples/month in Bengaluru
- 20% Ebitda profitability in Bengaluru
- 60-min collection
- 6-hour reports
- Dr Lal FY26 revenue ₹2,763 crore
- Metropolis FY26 ₹1,646 crore
- India diagnostics market $15-16 bn by 2030
- 12% CAGR
Why this matters
Dr Lal, Metropolis and Tata 1mg now face a venture-funded speed insurgent in their four richest metros, raising the strategic value of either acquiring Orange Health or partnering on last-mile collection before it compounds share.